Member Info for share4

Interesting timing that he left when the poc had been completed

Are you going to answer my questions Truro?

My point was to highlight this RNS adds nothing to the bottom line which you've confirmed. Thanks.

"in this context" it means more? Is that because companies that complete a successful proof of concept usually go onto something else rather than focusing on commercialising the thing they've just spent a year proving? Ludicrous.

Exactly the way I read it, proof of concept was all nice and that and got positive feedback but we'd better look at some other things.

Positive feedback. What does that add to the bottom line?
Exploring further development projects. What does that add to the bottom line?
Significant future commercial potential. What does that add to the bottom line?

So if you disagree that this is "game changing news" you get your post removed on here. Be careful people.

For how much revenue?

Here's an example elevator pitch, this company is going to sell thousands of digitalglassware at 150k a pop so the market cap should be around 500 million. Hope no horses were lead by you to that water!

Predicting 50p since 2019 isn't leading horses to water, but giving a simple elevator pitch on the growth product you are claiming exists is. I think you might be the wrong way around on this one.

There are no tools of a similar ilk because it is not producing tools. I asked you for an elevator pitch... where is it?

Oh just filter, nobody cares. Riddler did it a long time ago when I told him the truth about DMTR. If you have to filter someone just for speaking an opinion on a company when they're not attacking you personally then perhaps you belong in an echo chamber rather than a shares forum.

Versus a sector that often has EV of x 50/100 annual revs

---

Honestly, he has the nerve to call people goons while not even understanding that this company can't be compared to companies making drugs or medical devices.

That's great. Are they producing it. What's the elevator pitch?

there's a huge difference between building a bespoke consultancy that takes a fee from projects with larger companies and a company that builds a killer product. there's been plenty of time to build a killer product and i don't think this company actually has any ambition.

and on that, you look at the board and they have people with a pharma background trying to create a tech company which are two completely different animals, not worth backing on that alone

i think at this point in time it comes down to whether you have faith in the bod rather than the technology

ob, judging by the revenue, no, if they had something people wanted it would have translated by now, it's that simple. the placing price indicates that they are going to have to pivot.

since when have physiomics built their own devices? you do know what a device is?

If I build some software to put in a plane I don't build planes